FATE THERAPEUTICS INC shareholders Q3 2023

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.

FATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 6,289$13,3330.00%
ROYAL BANK OF CANADA 14,356$30,0000.00%
Legal & General Group Plc 54,531$115,6070.00%
GEODE CAPITAL MANAGEMENT, LLC 1,775,344$3,764,1930.00%
BARCLAYS PLC 118,751$2520.00%
STATE STREET CORP 2,271,925$4,816,4810.00%
JANUS HENDERSON GROUP PLC 33,963$72,1690.00%
Renaissance Technologies 109,219$2320.00%
GUGGENHEIM CAPITAL LLC 21,572$45,7330.00%
TEACHER RETIREMENT SYSTEM OF TEXAS 22,348$470.00%
PRICE T ROWE ASSOCIATES INC /MD/ 977,862$2,0740.00%
External links

This page lists FATE THERAPEUTICS INC's shareholders in Q3 2023. To view FATE THERAPEUTICS INC's shareholder history, click here.